直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan

Search Finnegan

Our Work

1 result

Experience

Representative Engagement: Finnegan secures $180M for CSRC in complex arbitrations - GENZYME CORP. v. CSRC et al., Case No. 01-19-0001-6937, 01-20-0000-5081

Finnegan secures $180M for CSRC in complex arbitrations Finnegan secures $180M for CSRC in complex arbitrations

01-19-0001-6937; 01-20-0000-5081, AAA

Our Insights

32 results

Lecture

Munich Licensing Summer Course 2026 Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Seminar

U.S. Patent Application and Litigation Developments and Strategies U.S. Patent Application and Litigation Developments and Strategies

November 14, 2025

Virtual

Seminar

FedEx AI Summit FedEx AI Summit

October 22, 2025

Memphis

Conference

LES 2025 Annual Meeting LES 2025 Annual Meeting

October 19-22, 2025

Boston

Lecture

Munich Licensing Summer Course Munich Licensing Summer Course

July 1-2, 2025

Munich

Articles

Case Summary: Patent Owner Can Sue Without Joining its Exclusive Licensee as a Party

Case Summary: Patent Owner Can Sue Without Joining its Exclusive Licensee as a Party Case Summary: Patent Owner Can Sue Without Joining its Exclusive Licensee as a Party

June 26, 2025

LES Insights

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments – June 2025 Spotlight on Upcoming Oral Arguments – June 2025

May 29, 2025

Articles

Structuring Patent Royalties to Avoid Unnecessary U.S. Customs Duties: Lessons from CBP Rulings

Structuring Patent Royalties to Avoid Unnecessary U.S. Customs Duties: Lessons from CBP Rulings Structuring Patent Royalties to Avoid Unnecessary U.S. Customs Duties: Lessons from CBP Rulings

May/June 2025

IP Litigator

News

2 results

Commentary

DOJ Draft SEP Bill: A 'Shot Across the Bow' for Rightsholders DOJ Draft SEP Bill: A 'Shot Across the Bow' for Rightsholders

December 24, 2021

World Intellectual Property Review

Commentary

Keys to Protecting Your MedTech AI from Competitors Keys to Protecting Your MedTech AI from Competitors

September 2021

Medical Design & Outsourcing

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP